Skip to content
10-Q

Quarterly Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-23-041311

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 14, 2023 42.96M sh
Shares Diluted Q3 2023 · Sep 30, 2023 42.96M sh
Shares Diluted Q3 2023 · Sep 30, 2023 42.96M sh
Shares Diluted Q3 2023 · Sep 30, 2022 42.96M sh
Shares Diluted Q3 2023 · Sep 30, 2022 42.96M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$59.67K
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$21.04K
Cash And Equivalents Q3 2023 · Sep 30, 2023 $84.55K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $121.86K
Stockholders Equity Q3 2023 · Sep 30, 2023 $31.74K
Stockholders Equity Q3 2023 · Dec 31, 2022 $19.32K
Stockholders Equity Q3 2023 · Sep 30, 2022 $2.72K
Stockholders Equity Q3 2023 · Dec 31, 2021 $38.17K
Total Liabilities Q3 2023 · Sep 30, 2023 $63.59K
Total Liabilities Q3 2023 · Dec 31, 2022 $108.47K
Total Assets Q3 2023 · Sep 30, 2023 $95.32K
Total Assets Q3 2023 · Dec 31, 2022 $127.78K
Sga Expense Q3 2023 · Sep 30, 2023 $54.96K
Sga Expense Q3 2023 · Sep 30, 2023 $119.44K
Sga Expense Q3 2023 · Sep 30, 2022 $46.44K
Sga Expense Q3 2023 · Sep 30, 2022 $91.44K
Net Income Q3 2023 · Sep 30, 2023 −$37.67K
Net Income Q3 2023 · Sep 30, 2023 $12.42K
Net Income Q3 2023 · Sep 30, 2022 −$5.44K
Net Income Q3 2023 · Sep 30, 2022 −$35.45K
Operating Income Q3 2023 · Sep 30, 2023 −$37.45K
Operating Income Q3 2023 · Sep 30, 2023 $35.17K
Operating Income Q3 2023 · Sep 30, 2022 −$5.44K
Operating Income Q3 2023 · Sep 30, 2022 −$35.46K
Revenue Q3 2023 · Sep 30, 2023 $17.52K
Revenue Q3 2023 · Sep 30, 2023 $154.61K
Revenue Q3 2023 · Sep 30, 2022 $41K
Revenue Q3 2023 · Sep 30, 2022 $55.98K